Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 50 results for "biotechnology regulatory authority of..."

Novozymes to expand enzymes in F&B industry in India

Mumbai Novozymes, a US$ two billion Danish biotech company, is focusing on expanding its enzymes base in the food and beverage industry in India. The company is increasingly looking at developing region specific applications to cater to the ... Financial Express, 1 week ago

Banking Newsletter - March 16 to 20, 2015

Top Stories India prepared for impact of Fed policy shift: Rajan RBI governor Raghuram Rajan expects volatility in the Indian financial market if US Federal Reserve raises interest rate, according to a media report. India is well prepared to ...
 India Infoline2 months ago

Half Yearly Report

RNS Press Release 26 March 2015 Interim Results to 31 December 2014 Epistem Holdings Plc (LSE: EHP), the biotechnology and personalised medicine company, announces today its unaudited interim results for the six months to 31 December 2014. The ...
 MoneyAM1 month ago EpiStem : Half Yearly Report  4 Traders1 month ago Epistem Holdings plc Half Yearly Report  ADVFN UK1 month ago

Researchers Submit Patent Application, "cGMP COMPLIANT INDELIBLE INK PENS, AND METHODS OF USING THE SAME", for Approval

By a News Reporter-Staff News Editor at Health & Medicine Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors PERRY, Stephen M. (Cary, NC); DRAGIC, Milan (Cary, NC), filed on January 7, 2015, was made ...
 Pharmacy Choice3 days ago

Cesca Therapeutics Receives IEC/IRB Approval to Initiate Acute Myocardial Infarction Study

Company News: Page (1) of 1 - 05/20/15 print page (May 20, 2015) RANCHO CORDOVA, Calif., May 20, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that ...
 Tutorial Finder4 days ago VALNEVA : Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of its net loss  4 Traders2 months ago VALNEVA Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of its net loss  Consumer Electronics Net2 months ago REG-VALNEVA Reports Annual Results 2014: the company announces a significant improvement to its EBITDA and a strong reduction of its net loss  Reuters2 months ago
[x]  
Global Education Magazine

Human Consciousness & Values for Solving Global Problems

Posted by admin on ยท Leave a Comment Director Research, Dean Social Sciences and Professor, CVMS, IASE Deemed University, Rajasthan, India. pathak06@gmail.com /http://existentialharmony.org / . . Abstract : Mother earth is ...
 Global Education Magazine2 months ago

SANOFI : Shantha will provide up to 37 million doses of Shan5(TM)

Shantha will provide up to 37 million doses of Shan5(TM) - Shan5(TM) pentavalent pediatric vaccine will protect children against 5 pediatric diseases - Lyon, France - March 17, 2015 - Sanofi Pasteur: http://www.sanofipasteur.com/en/, the ...
 4 Traders2 months ago Shantha will provide up to 37 million doses of Shan5(TM)  FierceVaccines2 months ago Press Release: Sanofi: Shantha will provide up to 37 million doses of Shan5(TM)  iMarketReports2 months ago Sanofi: Shantha will provide up to 37 million doses of Shan5(TM)  EuroInvestor2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biotechnology regulatory authority of india b
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less